Moles, eye colour and the genetics of skin cancer
14 November, 2011 by Tim DeanA new study has identified that a gene variation associated with a greater number of moles and non-blue eye colour is linked to an increased risk of melanoma.
Tackling breast cancer requires national coordination: report
11 November, 2011 by Staff WritersA new report by the Economist Intelligence Unit says "fragmentation" of research, funding and treatment of breast cancer is hampering Australia's response to the disease.
Feature: New pathways for cancer therapy
08 November, 2011 by Fiona WylieAssociate Professor Stuart Pitson has been delving into the world of sphingolipid-mediated cell signalling pathways, particularly their enticing possibilities in cancer treatment.
Protein microarray uncovers malaria immunity
03 November, 2011 by Staff WritersResearchers at the Walter and Eliza Hall institute have revealed some enticing information about how people develop immunity to malaria, opening the door to possible diagnostics and therapies.
Ramaciotti Awards Slideshow
28 October, 2011 by Staff WritersThe Ramaciotti Foundations are collectively one of the largest private contributors to biomedical research in Australia, and having recently celebrated their 40th anniversary, have granted more than $51 million to research projects since 1970. Last week saw the latest slew of awards and grants issued, with more than $2.6 million issued to biomedical researchers around the nation.
Melanoma gene discovery may improve diagnosis and treatment
10 October, 2011 by Tim DeanFour new genes associated with melanoma susceptibility have been uncovered, revealing insights into skin cancer and raising the prospect of improved diagnosis and treatment.
Feature: Collapsing breast cancer’s niche
05 October, 2011 by Fiona WylieTwo Sydney researchers coming from entirely different backgrounds have teamed up to find out how the hedgehog pathway is being hijacked by breast cancer calls – with a potential win-win result for patients.
Vegenics files for IND for anti-cancer drug
04 October, 2011 by Staff WritersCircadian subsidiary, Vegenics, has submitted investigational new drug (IND) application for anti-cancer drug VGX-100.
Fat’s proteomic fingerprint sheds light on Type 2 diabetes
30 September, 2011 by Staff WritersA proteomic analysis of fat cells has lent insight into the role of insulin, providing potential targets for future Type 2 diabetes treatments.
Insight into how chemotherapy causes low platelets
26 September, 2011 by Staff WritersNew research uncovering how chemotherapy reduces platelet count in cancer patients may lead to new strategies to prevent chemotherapy-induced thrombocytopenia.
Gene ‘switch’ discovered for Type 2 diabetes
23 September, 2011 by Staff WritersA single gene has been found to control the onset of Type 2 diabetes after eating a high-fat diet, lending hope that a new treatment might be found.
Feature: Dosing the poison
21 September, 2011 by Graeme O'NeillAssociate Professor Martina Stenzel is developing polymer nanoparticles that can help target the effects of chemotherapy drugs on tumours while sparing healthy cells.
Genetic link between schizophrenia and bi-polar discovered
19 September, 2011 by Tim DeanTwo landmark genetic studies have found 11 regions that are associated with both diseases, suggesting some common underlying causes.
Feature: Going rogue
06 September, 2011 by Fiona WylieTony Purcell is using the latest in immunoproteomics technology to detect, monitor and hopefully eliminate rogue T cells that cause autoimmune disease with minimal collateral damage to the good guys.
Trial of xenotransplantation treatment for diabetes kicks off in Argentina
22 August, 2011 by Staff WritersLiving Cell Technologies has begun a trial of its xenotransplantation therapy for the treatment of Type 1 diabetes in Argentina.
